World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
150
Citations
112306
World Ranking
1140
National Ranking
657

Samuel Z. Goldhaber publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Samuel Z. Goldhaber sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 992 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Samuel Z. Goldhaber D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Samuel Z. Goldhaber sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 150 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2015 - Distinguished Scientist Award, American Heart Association
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Samuel Z. Goldhaber is affiliated with Brigham and Women's Hospital in the United States. Their research primarily focuses on medicine, with significant contributions to cardiology and cardiovascular medicine, internal medicine, surgery, epidemiology, and infectious diseases.

The scientist's main topics of work include:

  • Venous Thromboembolism Diagnosis and Management
  • Atrial Fibrillation Management and Outcomes
  • Acute Myocardial Infarction Research
  • COVID-19 Clinical Research Studies
  • Acute Ischemic Stroke Management
  • Cardiac Arrhythmias and Treatments
  • Health Systems, Economic Evaluations, Quality of Life

Recent papers by Samuel Z. Goldhaber include:

  • Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit, 2021, JAMA
  • Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19, 2020, Journal of the American College of Cardiology
  • Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research, 2020, Thrombosis and Haemostasis
  • Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database, 2020, The Lancet Respiratory Medicine
  • Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19, 2021, Journal of the American College of Cardiology

Frequent coauthors in their work include:

  • Gregory Piazza
  • Behnood Bikdeli
  • Candrika D. Khairani
  • Harlan M. Krumholz
  • Manuel Monréal

Samuel Z. Goldhaber has published extensively in several prominent journals, notably:

  • Journal of the American College of Cardiology
  • Circulation
  • Thrombosis Research
  • Journal of Thrombosis and Thrombolysis
  • European Heart Journal

The scientist has been recognized with the Distinguished Scientist Award from the American Heart Association in 2015 and is a member of the Association of American Physicians.

Best Publications

  • Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

    Clive Kearon;Elie A. Akl;Anthony J. Comerota;Paolo Prandoni

  • Acute pulmonary embolism: clinical outcomes in the international cooperative pulmonary embolism registry (ICOPER)

    Samuel Z Goldhaber;Luigi Visani;Marisa De Rosa

  • Dabigatran versus warfarin in the treatment of acute venous thromboembolism

    Sam Schulman;Clive Kearon;Ajay K. Kakkar;Patrick Mismetti

  • COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

    Behnood Bikdeli;Mahesh V. Madhavan;David Jimenez;Taylor Chuich

  • Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

    Clive Kearon;Susan R. Kahn;Giancarlo Agnelli;Samuel Goldhaber

  • Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension A Scientific Statement From the American Heart Association

    Michael R. Jaff;M. Sean McMurtry;Stephen L. Archer;Mary Cushman

  • An overview of randomized trials of rehabilitation with exercise after myocardial infarction.

    Gerald T. O'connor;Julie E. Buring;Salim Yusuf;Samuel Z. Goldhaber

  • Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study.

    Alexander T Cohen;Victor F Tapson;Jean-Francois Bergmann;Samuel Z Goldhaber

  • Fibrinolysis for Patients with Intermediate- Risk Pulmonary Embolism

    Guy Meyer;Eric Vicaut;Thierry Danays;Giancarlo Agnelli

  • Moderate Alcohol Intake, Increased Levels of High-Density Lipoprotein and Its Subfractions, and Decreased Risk of Myocardial Infarction

    Gaziano Jm;Buring Je;Breslow Jl;Goldhaber Sz

  • Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

    Sam Schulman;Clive Kearon;Ajay K. Kakkar;Sebastian Schellong

  • Pulmonary embolism and deep vein thrombosis

    Samuel Z Goldhaber;Henri Bounameaux

  • Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

    Alain Leizorovicz;Alexander T Cohen;Alexander G G Turpie;Carl-Gustav Olsson

  • Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

    Sam Schulman;Ajay K. Kakkar;Samuel Z. Goldhaber;Sebastian Schellong

  • Electronic alerts to prevent venous thromboembolism among hospitalized patients

    Nils Kucher;Sophia Koo;Rene Quiroz;Joshua M. Cooper

  • Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism

    Paul M Ridker;Samuel Z. Goldhaber;Ellie Danielson;Yves Rosenberg

  • Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion

    S.Z. Goldhaber;P.C. Come;R.T. Lee;E. Braunwald

  • Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

    Paul M Ridker;Brendan M Everett;Aruna Pradhan;Jean G MacFadyen

  • Massive Pulmonary Embolism

    Nils Kucher;Elisa Rossi;Marisa De Rosa;Samuel Z. Goldhaber

  • A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.

    Gregory Piazza;Benjamin Hohlfelder;Michael R. Jaff;Kenneth Ouriel

Frequent Co-Authors

Ajay K. Kakkar
Ajay K. Kakkar University College London
Alexander G.G. Turpie
Alexander G.G. Turpie McMaster University
Adrian F. Hernandez
Adrian F. Hernandez Duke University
Russell D. Hull
Russell D. Hull University of Calgary
Shinya Goto
Shinya Goto Tokai University
C. Michael Gibson
C. Michael Gibson Beth Israel Deaconess Medical Center
Robert A. Harrington
Robert A. Harrington Cornell University
Sam Schulman
Sam Schulman McMaster University
Paolo Prandoni
Paolo Prandoni University of Padua
Clive Kearon
Clive Kearon McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine in the USA offers many related educational and career opportunities beyond traditional medical school. Online programs are increasingly popular for students seeking flexibility and workforce entry at a faster pace or at a reduced cost.

For those interested in patient care, accelerated lpn program options allow students to become licensed practical nurses quickly and conveniently. Nurses looking to specialize can consider psych nurse practitioner programs, which offer advanced clinical training and new career paths in mental health care.

If you’re seeking roles in healthcare leadership or administration rather than direct patient care, consider a bachelors in healthcare administration. This degree prepares you for entry-level management or support roles in hospitals and clinics. For further advancement, affordable mha online programs are available for those pursuing senior administration positions or hospital leadership roles.

Exploring these online degrees can lead to rewarding careers across the healthcare spectrum, providing diverse alternatives for anyone interested in the field of medicine.

Best Scientists Citing Samuel Z. Goldhaber

Trending Scientists

Recently Published Articles